Septodont Holding
Since its foundation in 1932, Septodont has been at the forefront of pharmaceutical dentistry developing, manufacturing and distributing a wide range of high quality dental products all over the world. Looking to the future, Septodont is also leveraging its competencies to bring innovative solutions in the medical field.
Company details
Find locations served, office locations
- Business Type:
- Manufacturer
- Industry Type:
- Medical Equipment
- Market Focus:
- Globally (various continents)
- Year Founded:
- 1932
Heritage & History
Septodont is a pharmaceutical and medical device company and was founded in 1932 by Annie & Nestor Schiller. When Henri Schiller took the leadership of the company, Septodont launched worldwide well established brands such as Endomethasone, Alvogyl and Detartrine. At the same time, the group also positioned itself among the frontrunners of dental anaesthetics in cartridges and leader in anesthesia. To do so, Septodont acquired in 1990 a manufacturing site in France dedicated to dental needles. Then the company introduced Septocaine® in 2000 in the United States, the very first articaine-based anesthetic. In 2000, Septodont acquired Novocol, an injectable anaesthetic facility based in Canada.
Beyond dental anesthesia, Septodont also invested in R&D towards bioactive and biocompatible therapeutic solutions, which led to the introduction of Biodentine and Bioroot RCS, two products based on the ABS Technology (Active Biosilicate Technology).
A long established presence in more than 150 countries.
Dedicated to serving the needs of dental professionals wherever they are, the company extended its global presence in the world by opening foreign subsidiaries in India (1998), China (2001), Brazil (2003) and in European countries (United Kingdom, Germany, Poland, Benelux, Italy and Spain).
Between 2014 and 2016, Septodont also acquired 2 companies in Brazil (TDV in 2014, a restorative accessory manufacturer and DLA in 2016, an injectable anesthetics facility) and one in Canada (Duoject – 2015, an engineering design firm for injection devices). In 2016 a new state-of-the-art manufacturing unit for injectable anesthetics has been opened in Saint-Maur-des-Fossés (France).
The world leader in dental pain management.
With 500 million cartridges of local anesthetic produced every year, Septodont is today world leader of dental anesthesia. The group counts 1,700 employees and remains a 100% family owned company under the leadership of its CEO, Olivier Schiller.
Our Vision
We enhance lives by providing innovative, safe and effective healthcare solutions.
Our Mission
-
Provide our customers with dental products and services that are unsurpassed in meeting their expectations for quality and performance.
-
Leverage our competencies in development, registration and manufacturing of dental and pharmaceutical products worldwide.
-
Develop a culture that challenges our people to deliver their highest level of performance in an atmosphere of self-fulfillment, respect and support of the individual, offering equal opportunity for personal growth to everyone.
Our Values
High performance implies how we go about doing our jobs, from production through sales we always focus on achieving our individual or team goals, which allows us to reach our overall business objectives. Both of these (standards or values) are closely linked through a corporate culture and working environment which is dedicated to success during changing times.
Because they are used for human healthcare, our products need to fully comply with all regulations and meet dentists expectations. To reach this objective, we manufacture them to strict quality standards.
Transparency means clear and open communication on all our activities. These core values are the soul of our company.
Everyone has a contribution and this contribution should be assessed through a fair process. To ensure maximum motivation, we also need to develop our people and facilitate promotion within the organization.
Septodont strives to meet dentists satisfaction thanks to the quality of our products, medical information and associated services.
We also want to meet our dealers expectations through excellent supply chain and strong marketing support for the promotion of our products. Doing so demonstrates our commitment to our customers and their importance to our company.